A cancer diagnosis is terrifying. But blindly trusting the first doctor? Not anymore. The medical second opinion market report by MRFR shows that oncology is the largest application, and the market is growing at 14.3% CAGR — from $5.61 billion to $24.42 billion by 2035. Why the surge? Because patients are more informed, and they want confirmation before starting harsh treatments.

What's driving demand? Medical errors. Studies suggest that second opinions change diagnosis or treatment in 30‑50% of cases. The medical second opinion market analysis highlights that telemedicine platforms are the largest service type, but in‑person consultations are the fastest‑growing — because some patients want face‑to‑face reassurance.

What's new? AI‑powered second opinions — algorithms that analyse medical images and suggest differential diagnoses. Also, subscription‑based second opinion services for employers.

The bottom line: if you have a serious diagnosis, get a second opinion. It's not about distrust — it's about due diligence. Your health is worth the extra effort.